Has Synakis successfully closed its oversubscribed pre-seed round?
Synakis Corp., a biotechnology company based in Toronto, has successfully closed an oversubscribed pre-seed financing round, raising CAD $2.6 million. The funds will be used...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info